Skip to main content
Erschienen in: Clinical Rheumatology 12/2020

13.06.2020 | Case Based Review

Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review

verfasst von: Sara Ganhão, Graça Barros Loureiro, Diana Rita Oliveira, Rúben dos-Reis-Maia, Francisca Aguiar, Rita Quental, Carla Moura, João Luís Barreira, Mariana Rodrigues, Iva Brito

Erschienen in: Clinical Rheumatology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessive disease resulting from loss-of-function pathogenic variants in ADA2 gene, which might resemble polyarteritis nodosa (PAN). The authors present two pediatric cases of ADA2 deficiency with phenotypic manifestations of PAN, including an unusual presentation with spinal cord ischemia. Also described is an assessment of ADA2 activity and gene expression profiling with description of a previously unreported homozygous variant, c.1226C > A (p.(Pro409His)), detected in a patient with consanguineous parents, confirmed by near-absent ADA2 plasma enzymatic activity. The authors suggest to first obtain enzymatic activity, whenever DADA2 is suspected, before proceeding to genetic testing, due to its excellent cost-effective results. Moreover, physicians must be aware of this monogenic disorder, especially in the case of early-onset PAN-like manifestations, having a family member with similar manifestations or having consanguineous parents suggesting an autosomal recessive inheritance pattern. Given the multi-organ involvement, recognizing the diverse manifestations is a crucial step towards timely diagnosis and management of this potentially fatal but often treatable syndrome.
Literatur
1.
Zurück zum Zitat Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee C-CR, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920CrossRefPubMedPubMedCentral Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, Stone DL, Chae JJ, Rosenzweig SD, Bishop K, Barron KS, Kuehn HS, Hoffmann P, Negro A, Tsai WL, Cowen EW, Pei W, Milner JD, Silvin C, Heller T, Chin DT, Patronas NJ, Barber JS, Lee C-CR, Wood GM, Ling A, Kelly SJ, Kleiner DE, Mullikin JC, Ganson NJ, Kong HH, Hambleton S, Candotti F, Quezado MM, Calvo KR, Alao H, Barham BK, Jones A, Meschia JF, Worrall BB, Kasner SE, Rich SS, Goldbach-Mansky R, Abinun M, Chalom E, Gotte AC, Punaro M, Pascual V, Verbsky JW, Torgerson TR, Singer NG, Gershon TR, Ozen S, Karadag O, Fleisher TA, Remmers EF, Burgess SM, Moir SL, Gadina M, Sood R, Hershfield MS, Boehm M, Kastner DL, Aksentijevich I (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370(10):921–931CrossRefPubMed Navon Elkan P, Pierce SB, Segel R, Walsh T, Barash J, Padeh S, Zlotogorski A, Berkun Y, Press JJ, Mukamel M, Voth I, Hashkes PJ, Harel L, Hoffer V, Ling E, Yalcinkaya F, Kasapcopur O, Lee MK, Klevit RE, Renbaum P, Weinberg-Shukron A, Sener EF, Schormair B, Zeligson S, Marek-Yagel D, Strom TM, Shohat M, Singer A, Rubinow A, Pras E, Winkelmann J, Tekin M, Anikster Y, King MC, Levy-Lahad E (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370(10):921–931CrossRefPubMed
3.
Zurück zum Zitat Ozen S, Bilginer Y, Deniz Batu E, Taşkıran E, Asuman Özkara H, Ünal S (2019) et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2 subtitle: deficiency of adenosine deaminase 2. J Rheumatol. https://doi.org/10.3899/jrheum.181384 Ozen S, Bilginer Y, Deniz Batu E, Taşkıran E, Asuman Özkara H, Ünal S (2019) et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2 subtitle: deficiency of adenosine deaminase 2. J Rheumatol. https://​doi.​org/​10.​3899/​jrheum.​181384
6.
Zurück zum Zitat Human A, Pagnoux C (2019) Diagnosis and management of ADA2 deficient polyarteritis nodosa. Int J Rheum Dis 22(Suppl 1):69–77CrossRefPubMed Human A, Pagnoux C (2019) Diagnosis and management of ADA2 deficient polyarteritis nodosa. Int J Rheum Dis 22(Suppl 1):69–77CrossRefPubMed
7.
Zurück zum Zitat Caorsi R, Omenetti A, Morreale A, Insalaco A, Buoncompagni A, Picco P, Malattia C, Gandolfo C, Aksentievic I, Martini A, Gattorno M (2015) Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency. Pediatr Rheumatol Online J 13(Suppl 1):O80CrossRefPubMedCentral Caorsi R, Omenetti A, Morreale A, Insalaco A, Buoncompagni A, Picco P, Malattia C, Gandolfo C, Aksentievic I, Martini A, Gattorno M (2015) Rapid and sustained effect of anti-TNF treatment in patients with ADA2 deficiency. Pediatr Rheumatol Online J 13(Suppl 1):O80CrossRefPubMedCentral
8.
Zurück zum Zitat Ozen S, Pistorio A, Iusan SM et al (2010) Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806CrossRefPubMed Ozen S, Pistorio A, Iusan SM et al (2010) Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798–806CrossRefPubMed
9.
Zurück zum Zitat Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, Grayson PC, Aksentijevich I (2018) Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol 9:1361 Springer JM, Gierer SA, Jiang H, Kleiner D, Deuitch N, Ombrello AK, Grayson PC, Aksentijevich I (2018) Deficiency of adenosine deaminase 2 in adult siblings: many years of a misdiagnosed disease with severe consequences. Front Immunol 9:1361
11.
Zurück zum Zitat Santo GC, Baldeiras I, Guerreiro R, Ribeiro JA, Cunha R, Youngstein T et al (2018) Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon’s syndrome of unknown cause. Cerebrovasc Dis 46(5–6):257–264. https://doi.org/10.1159/000495794 Santo GC, Baldeiras I, Guerreiro R, Ribeiro JA, Cunha R, Youngstein T et al (2018) Adenosine deaminase two and immunoglobulin M accurately differentiate adult Sneddon’s syndrome of unknown cause. Cerebrovasc Dis 46(5–6):257–264. https://​doi.​org/​10.​1159/​000495794
14.
Zurück zum Zitat Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yılmaz T, Gümüş E, Barış S, Kuşkonmaz B, Ozgur TT, Bali P, Santisteban I, Orhan D, Yüce A, Cetinkaya D, Boztug K, Hershfield M, Sanal O, Tezcan İ (2018) ADA deficiency: evaluation of the clinical and laboratory features and the outcome. J Clin Immunol 38(4):484–493. https://doi.org/10.1007/s10875-018-0496-9 Cagdas D, Gur Cetinkaya P, Karaatmaca B, Esenboga S, Tan C, Yılmaz T, Gümüş E, Barış S, Kuşkonmaz B, Ozgur TT, Bali P, Santisteban I, Orhan D, Yüce A, Cetinkaya D, Boztug K, Hershfield M, Sanal O, Tezcan İ (2018) ADA deficiency: evaluation of the clinical and laboratory features and the outcome. J Clin Immunol 38(4):484–493. https://​doi.​org/​10.​1007/​s10875-018-0496-9
15.
16.
17.
18.
Zurück zum Zitat Fayand A, Sarrabay G, Belot A, Hentgen V, Kone-Paut I, Grateau G, Melki I, Georgin-Lavialle S (2018) Multiple facets of ADA2 deficiency: vasculitis, auto-inflammatory disease and immunodeficiency: a literature review of 135 cases from literature. Rev Med Interne 39(4):297–306. https://doi.org/10.1016/j.revmed.2017.11.006 Fayand A, Sarrabay G, Belot A, Hentgen V, Kone-Paut I, Grateau G, Melki I, Georgin-Lavialle S (2018) Multiple facets of ADA2 deficiency: vasculitis, auto-inflammatory disease and immunodeficiency: a literature review of 135 cases from literature. Rev Med Interne 39(4):297–306. https://​doi.​org/​10.​1016/​j.​revmed.​2017.​11.​006
Metadaten
Titel
Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review
verfasst von
Sara Ganhão
Graça Barros Loureiro
Diana Rita Oliveira
Rúben dos-Reis-Maia
Francisca Aguiar
Rita Quental
Carla Moura
João Luís Barreira
Mariana Rodrigues
Iva Brito
Publikationsdatum
13.06.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Rheumatology / Ausgabe 12/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05210-4

Weitere Artikel der Ausgabe 12/2020

Clinical Rheumatology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.